A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

November 30, 2010

Study Completion Date

February 28, 2011

Conditions
Non Small Cell Lung Cancer
Interventions
BIOLOGICAL

Mapatumumab

30 mg/kg IV (in the vein), on day 1 of each 21 day cycle

BIOLOGICAL

Mapatumumab

10 mg/kg IV (in the vein), on day 1 of each 21 day cycle

DRUG

Paclitaxel

200 mg/m\^2 IV (in the vein), on day 1 of each 21 day cycle

DRUG

Carboplatin

AUC 6.0 mg min/ml IV (in the vein), on day 1 of each 21 day cycle

Trial Locations (33)

1145

Fővárosi Önkormányzat Uzsoki Utcai Kórház, Budapest

1529

Országos Korányi TBC és Pulmonológiai Intezet, Budapest

4032

Debrecen University, Medical and Health Center, Dept of Oncology, Debrecen

4043

Kenézy Gyula Kórház, Debrecen, Pulmonológia, Debrecen

10117

Charite - Campus Mitte, Universitätsmedizin Berlin, Abteilung Onkologie und Hämatologie, Berlin

Universitätsmedizin Berlin, Centrum für Innere Medizin, Berlin

20815

Chevy Chase Health Care, Chevy Chase

21201

University of Maryland, Greenebaum Cancer Center, Baltimore

22031

Fairfax-Northern Virginia Hematology Oncology, PC, Fairfax

22927

Krankenhaus Großhansdorf, Großhansdorf

26121

Pius-Hospital, Oldenburg

29425

Medical University of South Carolina: Hollings Cancer Center, Charleston

33401

Palm Beach Cancer Institute, West Palm Beach

34741

Osceola Cancer Center, Kissimmee

35213

Birmingham Hematology and Oncology Associates, LLC, Birmingham

37203

The Sarah Cannon Cancer Center, Nashville

39120

Universitätsklinik Magdeburg, Klinik für Kardiologie, Angiologie und Pneumologie, Magdeburg

40202

Kentuckiana Cancer Institute, PLLC, Louisville

49076

Paracelsus Klinik, Zentrum für Tumordiagnostik und -therapie, Osnabrück

55131

Klinikum der Johannes-Gutenberg-Universität Mainz, Mainz

60076

Orchard Research, LLC, Skokie

60525

LaGrange Oncology Associates, LaGrange

60612

Rush University Medical Center, Chicago

68167

Universitätsklinikum Mannheim, Chirurgische Klinik, Mannheim

78229

UT Health Science Center at San Antonio, Be Well Center, San Antonio

80045

University of Colorado Health Sciences Center, Aurora

82131

Asklepios Fachkliniken München-Gauting, Gauting

92270

Desert Hematology Oncology Medical Group, Inc., Rancho Mirage

400015

Institutul Oncologic 'Prof . Dr. I. Chiricuta' Cluj-Napoca, Cluj-Napoca

410032

Spitalul Clinic Judetean Oradea, Oncology Department, Oradea

07601

Hackensack University Medical Center, Hackensack

06120

Krankenhaus Martha-Maria Halle-Dölau, Halle

022328

Institutul Oncologic 'Prof Dr. Al Trestioreanu' Bucuresti, Bucharest

Sponsors
All Listed Sponsors
lead

Human Genome Sciences Inc.

INDUSTRY